Role of Ultrasound Elastography in Differentiation of Peripheral Lung Lesions

Sponsor
Assiut University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05759390
Collaborator
(none)
60
1
12
5

Study Details

Study Description

Brief Summary

Advancements in imaging capacities and the development of a precise puncture-guiding transducer have made transthoracic ultrasonography a useful diagnostic tool for evaluating peripheral subpleural lung tumours. Different human tissues have varying levels of elasticity because of the properties of the extracellular matrix.

Pleural two-dimensional (2D) shear-wave elastography (SWE) can be used to differentiate between malignant pleural effusion and benign pleural disease.

Transthoracic 2D-SWE uses acoustic radiation force and assesses the velocity of tissue displacement propagation in multiple focal zones. The shear waves are monitored in 2D by creating a near-cylindrical shear-wave cone, enabling measurement of the shear-wave speed or Young's modulus (E) on a colour quantitative elastogram. Based on the hypothesis that transthoracic 2D-SWE could add accurate tissue stiffness information to B-mode grayscale ultrasound images and help in differentiating lung malignancy from benign lung lesions.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Ultrasound elastography

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Role of Ultrasound Elastography in Differentiation of Peripheral Lung Lesions
Actual Study Start Date :
Jun 1, 2022
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Outcome Measures

Primary Outcome Measures

  1. Evaluate the predictive value of transthoracic 2 Dimension- Shear Wave Elastography (2D-SWE) in the diagnosis of peripheral lung lesions. [1 MONTH]

    Peripheral lung lesions evaluated using 2 Dimension- Shear Wave Elastography to differentiate between benign and malignant lung lesions comparing the results to definitive diagnostic method either microbiological results and pathological specimens obtained by biobsy if indicated.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Radiographic evidence of pulmonary lesions
Exclusion Criteria:
  • Patients less than 18 years.

  • Patients refusing to participate in the study.

  • Inability to hold breath for at least 5 s.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assiut university hospitals Assiut Egypt 71515

Sponsors and Collaborators

  • Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Waleed Gamal Elddin Khaleel, Lecturer of chest diseases and tuberculosis, Assiut University
ClinicalTrials.gov Identifier:
NCT05759390
Other Study ID Numbers:
  • Elastography in Lung
First Posted:
Mar 8, 2023
Last Update Posted:
Mar 8, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Waleed Gamal Elddin Khaleel, Lecturer of chest diseases and tuberculosis, Assiut University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 8, 2023